万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>生物科学>>发育生物学
您的位置:万维书刊网 >>sci/e期刊大全 >>生物科学>>遗传学

GENESIS《起源:遗传与发育杂志》 (官网投稿)

简介
  • 期刊简称GENESIS
  • 参考译名《起源:遗传与发育杂志》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率5.50%
  • 主要研究方向生物学-DEVELOPMENTAL BIOLOGY 发育生物学;GENETICS & HEREDITY 遗传学

主要研究方向:

等待设置主要研究方向
生物学-DEVELOPMENTAL BIOLOGY 发育生物学;GENETICS & HEREDITY 遗传学

GENESIS《起源:遗传与发育杂志》(月刊). genesis: The Journal of Genetics and Development presents reviews, full research articles, short research letters, ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://onlinelibrary.wiley.com/journal/1526968x

3、投稿网址:

http://mc.manuscriptcentral.com/dvg-wiley

4、官网邮箱:dvg@wiley.com

DVGprod@wiley.com

samoody@gwu.edu

5、期刊刊期:月刊,一年出版十二期。

202156日星期四

                             

 

投稿须知【官网信息】

 

AUTHOR GUIDELINES

1. SUBMISSION

Note to authors: Recent publication of similar original research elsewhere by different authors does not necessarily preclude our consideration of your manuscript. The editors of genesis may consider your findings, if your manuscript is submitted within a reasonable time that would suggest a concurrent research effort. Please explain in your cover letter, including roughly when your research had begun before the prior publication.

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted via the journal’s ScholarOne site: https://mc.manuscriptcentral.com/dvg-wiley. For more details on how to use ScholarOne, visit www.wileyauthors.com/scholarone. Note, this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.

The submission system will prompt the author to use an ORCiD ID (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at authorservices.wiley.com/statements/data-protection-policy.

For help with submissions, please contact the Editorial Office: dvg@wiley.com. When necessary, the Editorial Office staff may refer questions to the Editor-in-Chief.

2. AIMS AND SCOPE

genesis: The Journal of Genetics and Development focuses on work that addresses the genetics of development and the fundamental mechanisms of embryological processes in animals and plants. With increased awareness of the interplay between genetics and evolutionary change, particularly during developmental processes, we encourage submission of manuscripts from all ecological niches and all species. Other areas of particular interest include: 1) the roles of epigenetics, microRNAs and environment on developmental processes; 2) genome-wide studies; 3) novel imaging techniques for the study of gene expression and cellular function; 4) comparative genetics and genomics and 5) animal models of human developmental disorders.

genesis presents reviews, full research articles, short research letters, and state-of-the-art technology reports that promote an understanding of the function of genes and the roles they play in complex embryological processes.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

The editors of genesis offer two tracks for consideration of original submissions:

Track 1: Status quo—new submissions are considered for peer review as usual.

Track 2: If your manuscript has already been peer-reviewed but rejected by another journal for reasons other than serious scientific flaws, you may submit to genesis your revised manuscript (with changes marked in red font), the original editor’s decision with attached reviews (as supplemental material) and a cover letter describing how you have responded to the previous journal’s reviewer comments. The Editor-in-Chief will then consider whether the previous critiques have been adequately addressed. She can make an immediate editorial decision on the acceptance of your manuscript without further review, or may seek advice from Associate Editors, members of the Editorial Board or outside referees. This track allows the Editor-in-Chief to expedite a quick decision on your previously reviewed manuscript.

Cover Letter:

All submissions must include a cover letter that explains the relevance of the work to the aims of the journal. It should include at least two suggested reviewers and name any potential reviewers the authors wish the editors to exclude due to conflicts of interest. Additional information is required in a track 2 submission, as described above.

Data and Reagent Sharing requirement::

The journal requires authors to share data sets, novel reagents and any animal lines supporting the results in the paper, for example by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Description of Submission Types:

genesis, The Journal of Genetics and Development particularly encourages manuscripts with a convergence of disciplines, including genetics, genomics, proteomics, computational modeling, and evolutionary biology. genesis highly encourages manuscripts that describe developmental mechanisms in diverse organisms, both animal and plant. Manuscripts that present work that exclusively considers adult systems, genetics or disease processes will not be considered.

Manuscripts can be submitted in one the four following formats:

RESEARCH ARTICLES: full-length reports that experimentally address a developmental problem. Research Articles should advance the field of development by mechanistic discoveries and by elucidating gene function. Manuscripts reporting purely descriptive science must be justified as having of particular interest to the research community to be considered for the journal. Research Articles include in order: Title page, Abstract (up to 200 words), Introduction, Results, Methods, Acknowledgments, References, and Figure legends (if applicable).

LETTERS: succinct, experiment-based research reports whose text is around 1,600-2,000 words (excluding Figure Legends, References and Methods) and four to six display items (Tables and Figures). Letters include in order: Title page, Abstract (up to 200 words), Text (combined Results and Discussion), Methods, Acknowledgments, References, and Figure legends (if applicable). The text has no subheadings. Up to 30 references may be cited.

TECHNOLOGY REPORTS: succinct reports that focus upon technology development and developmental genetics resources. Technology Reports will follow the same format as Letters. In addition, the following criteria will be used to evaluate the suitability of Technology Reports for publication in genesis:

The technology or reagent must provide an advance in addressing a developmental problem or process. Describing transgenic animals that are useful exclusively to an adult system or disease state will not be considered.

If a transgenic line is reported, how this line is distinct from other published lines must be described.

The developmental relevance of the technology/reagent needs to be experimentally demonstrated. This includes showing the expression of a reporter at various stages, including both whole mount and tissue section analyses. The demonstration that a ubiquitous Cre-deletion of a floxed allele results in a phenotype already reported for a gene knock-out will not be sufficient.

For new Cre-driver lines, evidence concerning the specificity and penetrance of the effects (i.e. weak or strong and whether activity is mosaic) and the length of time/stage before Cre activity is detected must be provided. There should be a proof of activity description.

For transgenic lines, information should be provided whether there are any phenotype(s) associated with homozygosity for the transgene insertion.

If a reagent or transgenic animal is described, it must be declared in the manuscript in the Methods section that it will be available to the research community upon acceptance of the manuscript.

REVIEWS: the topics of the manuscript are flexible, but they are intended to reach a broad audience of readers in developmental genetics—from investigators in the field, to students learning the material for the first time. Therefore, it is important that the reviews start generally or with a historical perspective to integrate the topic into a larger context. The bulk of the review should be a critical analysis of the current field and should end with important yet-unresolved questions, speculations, and directions for the field in the future. All other formats for the Review are as listed below for Manuscripts.

4. PREPARING THE SUBMISSION

Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.

Main Text File

The text file should be presented in the following order:

The title;

The full names of the authors (do not include academic degrees);

The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;

Grant numbers (as applicable-to ensure proper identification of funders with publication requirements-see note under Author Licensing; below);

Abstract and keywords;

Main text;

Acknowledgments;

References;

Tables (each table complete with title and footnotes);

Figure legends;

Appendices (if relevant)

Figures and supporting information should be supplied as separate files. Figures must be clearly labeled.

Authorship

Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.

Acknowledgements

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the Conflict of Interest section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract

Please provide an abstract of 200 words containing the major keywords summarizing the article.

Keywords

Please provide three to five keywords.

Main Text

The journal uses US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.

Text headings of Research Articles should follow the format: Title page, Abstract, Introduction, Results, Discussion, Methods, Acknowledgments.

References

The accuracy of references is the responsibility of the authors. Only published papers and those in press may be included in the reference list. Unpublished data and submitted manuscripts must be cited parenthetically within the text. Personal communications should also be cited within the text; permission in writing from the communicator is required.

References should be prepared according to the Publication Manual of the American Psychological Association (6th edition). The APA website includes a range of resources for authors learning to write in APA style, including an overview of the manual, free tutorials on APA Style basics, and an APA Style Blog. For more information about APA referencing style, please also refer to the APA FAQ.

EndNote users can download the style here.

According to APA style, in text citations should follow the author-date method whereby the author's last name and the year of publication for the source should appear in the text, for example, (Jones, 1998). The complete reference list should appear alphabetically by name at the end of the paper.

Authors should note that the APA referencing style requires that a Digital Object Identifier (DOI) be provided for all references where available. Also, for journal articles, issue numbers are not included unless each issue in the volume begins with page one.

Reference examples follow:

Journal article

Beers, S. R., & De Bellis, M. D. (2002). Neuropsychological function in children with maltreatment-related posttraumatic stress disorder. The American Journal of Psychiatry, 159, 483–486. doi:10.1176/appi.ajp.159.3.483

Book

Bradley-Johnson, S. (1994). Psychoeducational assessment of students who are visually impaired or blind: Infancy through high school (2nd ed.). Austin, TX: Pro-ed.

Internet Document

Norton, R. (2006, November 4). How to train a cat to operate a light switch [Video file]. Retrieved from http://www.youtube.com/watch?v=Vja83KLQXZs

Footnotes

Footnotes should not be used in the main text.

Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P- values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures

Although authors are encouraged to send the highest quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Figures submitted in color will be published in color free of charge.

Guidelines for Cover Submissions

If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines.

Additional Files

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on Supporting Information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points

The following points provide general advice on formatting and style.

Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.

Numbers: numbers under 10 should be spelt out, except for: measurements with a unit (8 mmol/L); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).

Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation, and Formatting Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Papers will only be sent to review if the Editors determine that the paper meets the appropriate quality and relevance requirements.

Except where otherwise stated, manuscripts are single-blind peer reviewed. Wiley's policy on the confidentiality of the review process is available here.

Data Sharing and Data Accessibility

The journal requires authors to share data sets, novel reagents and any animal lines supporting the results in the paper, for example by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical PracticeUS Federal Policy for the Protection of Human Subjects;. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (an eye bar must not be used because of insufficient de- identification). Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.

UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).

European authors outside the UK should conform to Directive 2010/63/EU.

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers are included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the Abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

……


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭